{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:40:07Z","timestamp":1751391607730,"version":"3.41.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL153646","U01-HL160277","R01-HL157108","R01-AG074989","U24-DK060990","R01-HL155599","R01-HL157264"],"award-info":[{"award-number":["R01-HL153646","U01-HL160277","R01-HL157108","R01-AG074989","U24-DK060990","R01-HL155599","R01-HL157264"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ccl.2025.03.003","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:01:41Z","timestamp":1745866901000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease"],"prefix":"10.1016","volume":"43","author":[{"given":"Blaise W.","family":"Abramovitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alavi","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rushelle","family":"Byfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordana B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ccl.2025.03.003_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","article-title":"Hypertension awareness, treatment, and control in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study","volume":"55","author":"Muntner","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"4 Suppl 2","key":"10.1016\/j.ccl.2025.03.003_bib2","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/j.ajkd.2007.12.012","article-title":"Hypertension and CKD: Kidney early evaluation program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004","volume":"51","author":"Rao","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.ccl.2025.03.003_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of hypertension in chronic kidney disease","volume":"79","author":"Pugh","year":"2019","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/HYPERTENSIONAHA.115.06487","article-title":"Prevalence and prognostic significance of apparent treatment resistant hypertension in chronic kidney disease: report from the chronic renal insufficiency cohort study","volume":"67","author":"Thomas","year":"2016","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.ccl.2025.03.003_bib5","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2215\/CJN.04110422","article-title":"Prevalence of apparent treatment-resistant hypertension in chronic kidney disease in two large US health care systems","volume":"17","author":"An","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/HYPERTENSIONAHA.120.16181","article-title":"Association of apparent treatment-resistant hypertension with differential risk of end-stage kidney disease across racial groups in the million veteran program","volume":"78","author":"Akwo","year":"2021","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.ccl.2025.03.003_bib7","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1097\/01.ASN.0000031805.09178.37","article-title":"Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP)","volume":"13","author":"Young","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ccl.2025.03.003_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11906-008-0069-z","article-title":"Hypertension management in patients with chronic kidney disease","volume":"10","author":"Palmer","year":"2008","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.ajkd.2020.12.013","article-title":"Association of blood pressure with the progression of CKD: findings from KNOW-CKD study","volume":"78","author":"Lee","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.ccl.2025.03.003_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/jhh.2016.81","article-title":"Hypertension is an important risk determinant for chronic kidney disease: results from a cross-sectional, observational study from a rural population in South India","volume":"31","author":"Anupama","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"4","key":"10.1016\/j.ccl.2025.03.003_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-159-4-201308200-00004","article-title":"Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study","volume":"159","author":"Kovesdy","year":"2013","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ccl.2025.03.003_bib12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/ajh\/hpu056","article-title":"Systolic blood pressure and outcomes in stage 3-4 chronic kidney disease patients: evidence from a Taiwanese cohort","volume":"27","author":"Chiang","year":"2014","journal-title":"Am J Hypertens"},{"issue":"8","key":"10.1016\/j.ccl.2025.03.003_bib13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/HJH.0000000000003168","article-title":"Blood pressure and kidney outcomes in patients with severely decreased glomerular filtration rate: a nationwide observational cohort study","volume":"40","author":"Al-Sodany","year":"2022","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.ccl.2025.03.003_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/M14-0488","article-title":"Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study","volume":"162","author":"Anderson","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ccl.2025.03.003_bib15","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/jamainternmed.2014.3279","article-title":"Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease","volume":"174","author":"Kovesdy","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.119.13123","article-title":"Association of blood pressure and risk of cardiovascular and chronic kidney disease in Hong Kong hypertensive patients","volume":"74","author":"Wan","year":"2019","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.ccl.2025.03.003_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jama.1997.03540400043029","article-title":"End-stage renal disease in African-American and white men. 16-year MRFIT findings","volume":"277","author":"Klag","year":"1997","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ccl.2025.03.003_bib18","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/HJH.0b013e3283577b05","article-title":"The great myth of office blood pressure measurement","volume":"30","author":"Myers","year":"2012","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/HYPERTENSIONAHA.109.141879","article-title":"Measurement of blood pressure in the office: recognizing the problem and proposing the solution","volume":"55","author":"Myers","year":"2010","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004536","article-title":"Implications of blood pressure measurement technique for implementation of systolic blood pressure intervention trial (SPRINT)","volume":"6","author":"Agarwal","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.ccl.2025.03.003_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jash.2016.03.186","article-title":"Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement","volume":"10","author":"Bhatt","year":"2016","journal-title":"J Am Soc Hypertens"},{"issue":"4","key":"10.1016\/j.ccl.2025.03.003_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/M17-3103","article-title":"The ACC\/AHA 2017 hypertension guidelines: both too much and not enough of a good thing?","volume":"168","author":"Cohen","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jch.12252","article-title":"Eliminating the human factor in office blood pressure measurement","volume":"16","author":"Myers","year":"2014","journal-title":"J Clin Hypertens"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/HYPERTENSIONAHA.118.11990","article-title":"History and justification of a national blood pressure measurement validated device listing","volume":"73","author":"Cohen","year":"2019","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.ccl.2025.03.003_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012960","article-title":"Blood pressure and the electronic health record: a work in progress","volume":"8","author":"Ahmad","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"27","key":"10.1016\/j.ccl.2025.03.003_bib26","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJM199812313392701","article-title":"Inadequate management of blood pressure in a hypertensive population","volume":"339","author":"Berlowitz","year":"1998","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ccl.2025.03.003_bib27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ccl.2025.03.003_bib28","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.2014.376","article-title":"Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease","volume":"87","author":"Ku","year":"2015","journal-title":"Kidney Int"},{"issue":"19","key":"10.1016\/j.ccl.2025.03.003_bib29","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1681\/ASN.2016030326","article-title":"BP control and long-term risk of ESRD and mortality","volume":"28","author":"Ku","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"10.1016\/j.ccl.2025.03.003_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012749","article-title":"Effect of blood pressure control on long-term risk of end-stage renal disease and death among subgroups of patients with chronic kidney disease","volume":"8","author":"Ku","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.ccl.2025.03.003_bib32","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"ACCORD study group. Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ccl.2025.03.003_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000446122","article-title":"Cardiovascular outcomes in action to control cardiovascular risk in diabetes: impact of blood pressure level and presence of kidney disease","volume":"43","author":"Papademetriou","year":"2016","journal-title":"Am J Nephrol"},{"issue":"17","key":"10.1016\/j.ccl.2025.03.003_bib34","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Group","year":"2010","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ccl.2025.03.003_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009326","article-title":"Effects of intensive systolic blood pressure lowering on cardiovascular events and mortality in patients with type 2 diabetes mellitus on standard glycemic control and in those without diabetes mellitus: reconciling results from ACCORD BP and SPRINT","volume":"7","author":"Beddhu","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ccl.2025.03.003_bib36","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","author":"Bi","year":"2024","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ccl.2025.03.003_bib37","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ccl.2025.03.003_bib38","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J Am Soc Nephrol : JASN (J Am Soc Nephrol)"},{"issue":"14","key":"10.1016\/j.ccl.2025.03.003_bib39","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ccl.2025.03.003_bib40","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"issue":"19","key":"10.1016\/j.ccl.2025.03.003_bib41","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccl.2025.03.003_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ccl.2025.03.003_bib43","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ccl.2025.03.003_bib44","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.7326\/M21-0834","article-title":"Management of blood pressure in patients with chronic kidney disease not receiving dialysis: synopsis of the 2021 KDIGO Clinical Practice Guideline","volume":"174","author":"Tomson","year":"2021","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ccl.2025.03.003_bib45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 Clinical Practice Guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ccl.2025.03.003_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2025.03.003_bib47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.ajkd.2021.09.013","article-title":"KDOQI US commentary on the 2021 KDIGO Clinical Practice Guideline for the management of blood pressure in CKD","volume":"79","author":"Drawz","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.ccl.2025.03.003_bib48","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1097\/HJH.0000000000002176","article-title":"Serious adverse events in patients with target-oriented blood pressure management: a systematic review","volume":"37","author":"Frey","year":"2019","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.ccl.2025.03.003_bib49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.amjmed.2017.01.004","article-title":"Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials","volume":"130","author":"Bangalore","year":"2017","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.ccl.2025.03.003_bib50","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1097\/01.ASN.0000089565.04535.4B","article-title":"Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"14","author":"Mitsnefes","year":"2003","journal-title":"J Am Soc Nephrol : JASN (J Am Soc Nephrol)"},{"issue":"4","key":"10.1016\/j.ccl.2025.03.003_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.108.110635","article-title":"Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study","volume":"52","author":"Flynn","year":"2008","journal-title":"Hypertension"},{"issue":"2 Suppl 4th Report","key":"10.1016\/j.ccl.2025.03.003_bib52","first-page":"555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ccl.2025.03.003_bib53","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"issue":"17","key":"10.1016\/j.ccl.2025.03.003_bib54","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"W\u00fchl","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ccl.2025.03.003_bib55","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ccl.2025.03.003_bib56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jamainternmed.2021.6819","article-title":"Prevalence of medications that may raise blood pressure among adults with hypertension in the United States","volume":"182","author":"Vitarello","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.ccl.2025.03.003_bib57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/HYPERTENSIONAHA.117.09091","article-title":"Blood pressure and risk of cardiovascular events in patients on chronic hemodialysis: the CRIC study (chronic renal insufficiency cohort)","volume":"70","author":"Bansal","year":"2017","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ccl.2025.03.003_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/HYPERTENSIONAHA.114.04334","article-title":"Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study","volume":"65","author":"Bansal","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ccl.2025.03.003_bib59","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1161\/HYP.0000000000000230","article-title":"Hypertension in patients treated with In-Center maintenance hemodialysis: current evidence and future opportunities: a scientific statement from the American heart association","volume":"80","author":"Bansal","year":"2023","journal-title":"Hypertension"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865125000177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865125000177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:16:11Z","timestamp":1751390171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865125000177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0733865125000177"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2025.03.003","relation":{},"ISSN":["0733-8651"],"issn-type":[{"type":"print","value":"0733-8651"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2025.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}